Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict. The post Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case appeared first on MedCity News.
COO Dave Caspers has taken over from his former boss, who had led the company since 2020. Along with its leadership change, the company also said it is seeing soft volumes “across our portfolio” this quarter.
To document the affordability challenges posed by out-of-pocket health care costs for people with Medicare, this brief analyzes out-of-pocket health care costs as a share of Social Security income and total income, including other sources of income in addition to Social Security.
In late August 2020, Ashlee Guidry and her staff kept a wary eye on guidance from local officials as Hurricane Laura passed over Cuba en route to southwestern Louisiana. Guidry was responsible for the safety of dozens of people living at Stonebridge Place, an assisted living and memory care facility in Sulphur. For days, Laura…
Healthcare organizations must orient their models around outcomes rather than technology and capabilities alone — and that can be done through novel accountable partnerships built on a care enablement platform. The post Bringing Joy Back to Healthcare: The Power of Accountable Partnerships appeared first on MedCity News.
The evolution of patient-matched medical devices represents more than just innovation in manufacturing and design. It marks a shift in clinical philosophy. Instead of shaping patients to fit implants, clinicians and device developers are harnessing technology to shape treatments around the individual. The post How Recent Changes in ‘Patient-Matched’ Technology Are Reshaping the Future of…
Dr. Monarez is the agency’s current acting director
That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral anticoagulants (DOACs) selected in the first round of Inflation Reduction Act (IRA) price negotiations in 2024: Eliquis®…
What will happen in the fall remains to be seen, but the pledge is facilitating an open dialogue within the senior care industry about the problems it’s facing, along with some fresh thinking on potential solutions. The post The Harris Campaign is Right to Pledge More Resources For Senior Home Care, But the Devil Will…
The National Cancer Institute, the federal research agency charged with leading the war against the nation’s second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official. “There are enough reports of it, enough interest in it, that we actually did — ivermectin, in particular — did engage in sort of…